VALACYCLOVIR: Affected lot may contain tablets intended for European market (different embossement)
Brand(s)
Last updated
Summary
Product
VALACYCLOVIR
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
---|---|---|---|---|---|
SIVEM Valacyclovir |
VALACYCLOVIR |
DIN 02442000 |
Tablet |
VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500 MG |
VC2302950A |
Issue
Affected lot may contain VALACYCLOVIR 500 MG tablets intended for European market (different embossement)
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
SIVEM Pharmaceuticals ULC.
4705 Dobrin Street,
Saint-Laurent, Quebec
H4R 2P7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-75978
Get notified
Receive notifications for new and updated recalls and alerts by category.